Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 66751 - 66775 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rifampin	Approved Investigational	ZNF436	80818	downregulated	Rifampin results in decreased expression of ZNF436 mRNA	1p36.12	A24040
Rifampin	Approved Investigational	ZNF441	126068	upregulated	Rifampin results in increased expression of ZNF441 mRNA	19p13.2	A24040
Rifampin	Approved Investigational	ZNF451	26036	downregulated	Rifampin results in decreased expression of ZNF451 mRNA	6p12.1	A24040
Rifampin	Approved Investigational	ZNF462	58499	downregulated	Rifampin results in decreased expression of ZNF462 mRNA	9q31.2	A24040
Rifampin	Approved Investigational	ZNF534	147658	downregulated	Rifampin results in decreased expression of ZNF534 mRNA	19q13.41	A24040
Rifampin	Approved Investigational	ZNF546	339327	downregulated	Rifampin results in decreased expression of ZNF546 mRNA	19q13.2	A24040
Rifampin	Approved Investigational	ZNF782	158431	downregulated	Rifampin results in decreased expression of ZNF782 mRNA	9q22.33	A24040
Rifapentine	Approved Investigational	CYP3A4	1576	upregulated	rifapentine results in increased expression of CYP3A4 mRNA	7q22.1	A20983 A24033
Rifaximin	Approved Investigational	ABCB1	5243	upregulated	rifaximin results in increased expression of ABCB1 mRNA	7q21.12	A24079
Rifaximin	Approved Investigational	ACTA2	59	upregulated	[NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of ACTA2 mRNA	10q23.31	A24080
Rifaximin	Approved Investigational	APOA4	337	upregulated	[NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of APOA4 mRNA	11q23.3	A24080
Rifaximin	Approved Investigational	CFD	1675	upregulated	[NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of CFD mRNA	19p13.3	A24080
Rifaximin	Approved Investigational	CIDEC	63924	upregulated	[NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of CIDEC mRNA	3p25.3	A24080
Rifaximin	Approved Investigational	COL1A1	1277	upregulated	[NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of COL1A1 mRNA	17q21.33	A24080
Rifaximin	Approved Investigational	CYP3A4	1576	upregulated	rifaximin results in increased expression of CYP3A4 mRNA	7q22.1	A24079
Rifaximin	Approved Investigational	DGAT2	84649	upregulated	[NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of DGAT2 mRNA	11q13.5	A24080
Rifaximin	Approved Investigational	LTA	4049	upregulated	[NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of LTA mRNA	6p21.33	A24080
Rifaximin	Approved Investigational	NR1I2	8856	upregulated	rifaximin results in increased expression of NR1I2 mRNA	3q13.33	A24081 A21590
Rifaximin	Approved Investigational	PPARG	5468	upregulated	[NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of PPARG mRNA	3p25.2	A24080
Riluzole	Approved Investigational	UTRN	7402	upregulated	Riluzole results in increased expression of UTRN mRNA	6q24.2	A22532
Rimonabant	Approved Withdrawn	XBP1	7494	upregulated	rimonabant results in increased expression of XBP1 mRNA	22q12.1	A22756
Risperidone	Approved Investigational	CRH	1392	downregulated	Risperidone results in decreased expression of CRH mRNA	8q13.1	A21633
Risperidone	Approved Investigational	HMGCR	3156	upregulated	Risperidone results in increased expression of HMGCR mRNA	5q13.3	A21634
Ritonavir	Approved Investigational	BCL2L1	598	downregulated	Ritonavir results in decreased expression of BCL2L1 mRNA	20q11.21	A24082
Ritonavir	Approved Investigational	BIRC5	332	downregulated	Ritonavir results in decreased expression of BIRC5 mRNA	17q25.3	A24082 A24083

Displaying entries 66751 - 66775 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability